Healthcare Services Group Inc
HCSG- Exchange
- Nasdaq
- Industry
- Services-Nursing & Personal Care Facilities
- SEC CIK
- 0000731012
In the last 90 days, Healthcare Services Group Inc insiders filed 0 open-market purchases and 1 sale; 274 institutions reported holding it in 13F filings for Q2 2026, worth $1.75B in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Healthcare Services Group Inc changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 207 | 195 | −12 |
| Shares | 73.5M | 73.9M | +358.2K (+0.5%) |
| Value | $766.7M | $766.4M | −$347.7K (0.0%) |
New holders (19)
Institutions that held Healthcare Services Group Inc at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Invenomic Capital Management LP | 406,588 | $4.22M | 0.22% |
| J. Goldman & Co LP | 401,922 | $4.17M | 0.23% |
| Stanley-Laman Group, Ltd. | 260,617 | $2.70M | 0.41% |
| Vident Advisory, LLC | 63,644 | $660.0K | 0.02% |
| Caxton Associates LP | 46,897 | $486.3K | 0.02% |
| Quest Partners LLC | 46,180 | $478.9K | 0.10% |
| Landscape Capital Management, L.L.C. | 32,532 | $337.4K | 0.03% |
| Y-Intercept (Hong Kong) Ltd | 31,382 | $325.4K | 0.03% |
| Arrowstreet Capital, Limited Partnership | 29,188 | $303.0K | 0.00% |
| Aristides Capital LLC | 26,172 | $271.4K | 0.14% |
| Brevan Howard Capital Management LP | 21,082 | $218.6K | 0.02% |
| Captrust Financial Advisors | 14,932 | $154.8K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 3,592 | $37.3K | 0.01% |
| Point72 Europe (London) LLP | 1,936 | $20.1K | 0.00% |
| Advisory Services Network, LLC | 1,519 | $15.8K | 0.00% |
| GAMMA Investing LLC | 428 | $4.04K | 0.00% |
| Ronald Blue Trust, Inc. | 73 | $1.00K | 0.00% |
| Parkside Financial Bank & Trust | 23 | $239 | 0.00% |
| Farther Finance Advisors, LLC | 20 | $207 | 0.00% |
Sold out (31)
Institutions that held Healthcare Services Group Inc at the end of Q3 2023 and filed for Q4 2023 without it.